Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Early research (Phase 1)Study completedNCT00606437
What this trial is testing

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

Who this might be right for
LymphomaMyelomaLeukemia+4 more
Duke University 40
Testing effectiveness (Phase 2)Study completedNCT00306111
What this trial is testing

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
University Hospital Tuebingen 14
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT04808167
What this trial is testing

Remote Ischemic Conditioning in HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantations
Children's Hospital Medical Center, Cincinnati 17
Testing effectiveness (Phase 2)Ended earlyNCT03615144
What this trial is testing

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Who this might be right for
Non-Malignant Hematologic Disorders
Memorial Sloan Kettering Cancer Center 1
Early research (Phase 1)Study completedNCT00641030
What this trial is testing

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Study completedNCT01613300
What this trial is testing

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Who this might be right for
B-Cell Lymphomas
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 33
Not applicableStudy completedNCT02452099
What this trial is testing

Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.

Who this might be right for
Multiple MyelomaLymphomasLeukemias
Maria Sklodowska-Curie National Research Institute of Oncology 150
Not applicableStudy completedNCT03602599
What this trial is testing

Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

Who this might be right for
Graft Versus Host Disease
National Institute of Dental and Craniofacial Research (NIDCR) 190
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Early research (Phase 1)Looking for participantsNCT03909412
What this trial is testing

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 18
Not applicableStudy completedNCT00445744
What this trial is testing

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more
Fred Hutchinson Cancer Center 52
Not applicableNot Yet RecruitingNCT07703657
What this trial is testing

Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationEpstein-Barr Virus ReactivationClinically Significant EBV DNAemia
Yang Donglin 168
Post-approval studies (Phase 4)Looking for participantsNCT06824103
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Who this might be right for
Graft vs. Host DiseaseChronic Graft vs. Host DiseaseCorticosteroid-refractory Chronic Graft vs. Host Disease
Novartis Pharmaceuticals 50
Not applicableLooking for participantsNCT04587856
What this trial is testing

Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto 38
Testing effectiveness (Phase 2)UnknownNCT02385019
What this trial is testing

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Graft vs Host Disease
Instituto de Medicina Molecular João Lobo Antunes 22
Next Page